Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes. Reply.

Husain, Mansoor

Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes. Reply. [electronic resource] - The New England journal of medicine 11 2019 - 2076-2077 p. digital

Publication Type: Letter; Comment

1533-4406

10.1056/NEJMc1913157 doi


Diabetes Mellitus, Type 2
Glucagon-Like Peptides
Humans
Hypoglycemic Agents